Parole chiave di "Response to different treatments in chronic myelogenous leukemia (CML) according to risk assessment at diagnosis: survival advantage with interferon alfa therapy."

Label

• Parole chiave di "Response to different treatments in chronic myelogenous leukemia (CML) according to risk assessment at diagnosis: survival advantage with interferon alfa therapy." (literal)
• Keywords of "Response to different treatments in chronic myelogenous leukemia (CML) according to risk assessment at diagnosis: survival advantage with interferon alfa therapy." (literal)

Insieme di parole chiave di

• Response to different treatments in chronic myelogenous leukemia (CML) according to risk assessment at diagnosis: survival advantage with interferon alfa therapy. (Abstract/Comunicazione in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1106)

Ha membro

• chronic myeloid leukemia (Parola chiave)
• interferon alpha (Parola chiave)
• survival (Parola chiave)

Incoming links:

Insieme di parole chiave

• Response to different treatments in chronic myelogenous leukemia (CML) according to risk assessment at diagnosis: survival advantage with interferon alfa therapy. (Abstract/Comunicazione in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1106)

Membro di

• survival (Parola chiave)
• interferon alpha (Parola chiave)
• chronic myeloid leukemia (Parola chiave)